A novel mediator of cholangiocarcinoma that has potential as a diagnostic and treatment target
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210824
- Recipient
-
The University Of Queensland UEI C13XVQRKLNC6
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $520,011
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Australia
Award details come from USAspending.gov.
About this award
The University of Queensland in Australia was awarded a $520,011 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from August 1, 2022 to July 31, 2025 on a novel mediator of cholangiocarcinoma that has potential as a diagnostic and treatment target. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research, including investigating medical solutions for battlefield care. This award will further those goals by funding research over three years that seeks to identify new targets for diagnosing and treating cholangiocarcinoma.
Quick answers
Who received award W81XWH2210824?
W81XWH2210824 was awarded to The University Of Queensland by Medical Command (Department of the Army) on August 1, 2022.
How much is award W81XWH2210824 worth?
$520,011 has been obligated on W81XWH2210824.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award